Log In
Print
BCIQ
Print
Print this Print this
 

Retaspimycin HCl (IPI-504)

Also known as: MEDI-561

  Manage Alerts
Collapse Summary General Information
Company Infinity Pharmaceuticals Inc.
DescriptionSmall molecule Hsp90 chaperone inhibitor
Molecular Target Heat shock protein 90 (Hsp90)
Mechanism of ActionHsp90 inhibitor
Latest Stage of DevelopmentPhase II
IndicationNon-small cell lung cancer (NSCLC)
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today